BMS: Funding Early Life Science Innovation: A Look at Pre-Venture Options

June 1, 2017

Share :

Time: 11:30AM - 2:00PM
Location: Lobby

This panel explores funding mechanisms to build early company value prior to venture investment, and, potentially, as an alternative to venture. Leveraging the experiences of both entrepreneurs and funding sources, the panel will explore academic-industry partnerships, government grants, accelerator competitions, and other options that can be used to resource and validate early life science ideas to the next stage of growth.


  • Arthur Bertelsen, Ph.D. | Vice President Research Collaborations, Bristol-Myers Squibb
  • Satish Jindal, Ph.D. | CEO, Allied-Bristol Life Sciences
  • Daniel Perez, Ph.D. | Founder & CEO Oxbridge Biotech Roundtable, and OneStart, and Founder & CEO Hinge Health
  • Carl Schoellhammer, Ph.D. | Co-Founder, Suono Bio
  • Doris Peterkin | CEO, OncoPep
  • Monica Anc | Senior Program Associate for Industry Programs, Massachusetts Life Sciences Center


11:30 AM | Registration Opens, Networking and Lunch
12:15 PM | Panel Discussion
1:30 PM | Q&A, Networking
2:00 PM | Program Close